ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

EGRX Eagle Pharmaceuticals Inc (CE)

0.65
0.01 (1.56%)
17 Jan 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2022 20152016201720182019202020212022
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 124.61M214.32M270.06M238.6M254.55M253.19M253.73M406.16M
Total Current Assets 122.26M109.11M188.7M163.84M179.45M166.07M172.61M188.75M
Cash and Equivalents 79.08M52.82M114.66M78.79M109.78M103.16M97.66M55.32M
Total Non-Current Assets 90.34M151.23M179.14M160.76M179.17M186.01M176.45M233.56M
Total Liabilities 34.26M63.09M90.92M77.84M75.38M67.18M77.28M172.6M
Total Current Liabilities 34.26M40.97M47.3M39.69M38.82M38.09M74.38M111.09M
Total Non-Current Liabilities 022.13M86.52M76.31M70.11M54.23M2.9M117.73M
Total Equity 90.34M151.23M179.14M160.76M179.17M186.01M176.45M233.56M
Common Equity 15k16k16k17k17k17k17k18k
Retained Earnings -107.11M-25.66M26.28M58.19M72.5M84.49M75.86M111.5M

Your Recent History

Delayed Upgrade Clock